questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the (a) pricing and (b) reimbursement system for multi-indication medicines does not disadvantage patients with (i) rare and (ii) ultra-rare conditions.
heading: Rare Diseases: Drugs